Skip to main content

Wynn Resorts says it gets UAE's first gambling license

1 min Mena Today

Hotel and casino operator Wynn Resorts said on Friday it had been awarded the first commercial gaming operator's license in the United Arab Emirates by the country's General Commercial Gaming Regulatory Authority.

Slot machine inside luxurious Wynn Resort Hotel, a 5-star, themed Paradise, Las Vegas Strip © Mena Today 

Slot machine inside luxurious Wynn Resort Hotel, a 5-star, themed Paradise, Las Vegas Strip © Mena Today 

Hotel and casino operator Wynn Resorts said on Friday it had been awarded the first commercial gaming operator's license in the United Arab Emirates by the country's General Commercial Gaming Regulatory Authority.

The Las Vegas-based casino firm said it was developing a luxury resort at Wynn Al Marjan Island in Ras Al Khaimah.

The project, under construction, is a joint venture between affiliates of Wynn Resorts, Marjan and RAK Hospitality Holding, Wynn said.

Ras Al Khaimah's government communications office, RAKTDA, and RAK Hospitality Holding did not immediately respond to Reuters requests for comment.

The UAE last month set up a federal entity to regulate gambling and hired veterans of the U.S. industry to lead it, ending years of speculation whether the country would allow gambling - illegal across the conservative Gulf region.

The moves to allow gambling are against a backdrop of intensifying economic competition in the Gulf, especially with Saudi Arabia. The UAE last month introduced a raft of liberal legal reforms as it tries to maintain its edge as the region's trade, tourism and financial hub.

Reporting by Disha Mishra

Related

United Arab Emirates

French narco bosses thrive in Dubai

French President Emmanuel Macron arrived in the United Arab Emirates on Sunday to spend Christmas with French troops deployed abroad and to highlight France’s strategic partnership with the Gulf state. 

United Arab Emirates

Emirates Drug Establishment authorises SMA gene therapy

The Emirates Drug Establishment has approved Itvisma (onasemnogene abeparvovec), a gene therapy for the treatment of spinal muscular atrophy (SMA) in eligible adults and children aged two and above.

Subscribe to our newsletter

Mena banner 4

To make this website run properly and to improve your experience, we use cookies. For more detailed information, please check our Cookie Policy.

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.